Related Experiment Videos

The pathopharmacology of malignant hyperpyrexia

Pharmacology & Therapeutics

|January 1, 1980

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia.

Journal of medical genetics·1995

Molecular cloning of the cDNA encoding human skeletal muscle triadin and its localisation to chromosome 6q22-6q23.

European journal of biochemistry·1995

The metabolism of D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle.

European journal of biochemistry·1994

Purification and characterization of D-myo-inositol (1,4,5)/(1,3,4,5)- polyphosphate 5-phosphatase from skeletal muscle.

Archives of biochemistry and biophysics·1994

Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism.

Biochemical and biophysical research communications·1994

A clinical grading scale to predict malignant hyperthermia susceptibility.

Anesthesiology·1994

See all related articles